US pharma tariffs may start low and rise, risking drug shortages, higher costs, and pressure on generics amid reshoring push.

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, ...

Speedier implementation of the Post-Approval Change Management Protocol is essential for it to have a positive effect on ...

Tariffs on APIs and finished drugs could take effect as early as August 1, with accelerated investigations raising urgency for supply chain planning.

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as ...

PMMI, The Association for Packaging and Processing Technologies, has announced some of the unique features being made ...

George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine ...

Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

Biodegradable weekly implant delivers stable levodopa levels, aiming to streamline Parkinson’s care while reshaping drug ...

The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address ...